1
|
Bao R, Xu P, Wang Y, Wang J, Xiao L, Li G, Zhang C. Bone marrow derived mesenchymal stem cells transplantation rescues premature ovarian insufficiency induced by chemotherapy. Gynecol Endocrinol 2018; 34:320-326. [PMID: 29073798 DOI: 10.1080/09513590.2017.1393661] [Citation(s) in RCA: 34] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/01/2023] Open
Abstract
Premature ovarian insufficiency (POI) is an important cause of infertility and also cause menopausal symptoms, which greatly reduced the quality of life for women. Hormone replacement therapy (HRT), as an important strategy, improved the quality of life for patients, however, the role of HRT in promoting fertility remains controversial. Therefore, seeking an optimal regime for POI becomes more urgent. In this study, we established POI model induced by CTX and BUS and utilized bone marrow derived mesenchymal stem cells (BM-MSCs) transplantation to treat the POI. We found that the decrease of estrogen and the increase of FSH induced by administration of CTX and BUS were rescued by BM-MSC transplantation. H&E staining and TUNEL assay showed that there were more healthy ovarian follicles and less apoptosis of ovarian cells after treatment with BM-MSCs. Further studies showed that there was an obvious decrease of Bax, p53, and p21 after transplantation, however, CyclinD2 was increased. In conclusion, our results demonstrated that BM-MSCs could restore injured ovarian function. Inhibiting apoptosis and promoting residual ovarian cell proliferation may contribute to the process.
Collapse
Affiliation(s)
- Riqiang Bao
- a Joint Programme of Nanchang University and Queen Mary University of London , Nanchang , Jiangxi , People's Republic of China
| | - Ping Xu
- b Second Clinical College , Nanchang University , Nanchang , Jiangxi , People's Republic of China
| | - Yishu Wang
- a Joint Programme of Nanchang University and Queen Mary University of London , Nanchang , Jiangxi , People's Republic of China
| | - Jing Wang
- c Department of Microbiology , Nanchang University , Nanchang , Jiangxi , People's Republic of China
| | - Li Xiao
- d Department of Cell Biology School of Medicine , Nanchang University , Nanchang , Jiangxi , People's Republic of China
| | - Gang Li
- d Department of Cell Biology School of Medicine , Nanchang University , Nanchang , Jiangxi , People's Republic of China
| | - Chunping Zhang
- d Department of Cell Biology School of Medicine , Nanchang University , Nanchang , Jiangxi , People's Republic of China
| |
Collapse
|
2
|
Rao Kandukuri L, Padmalatha V, Kanakavalli M, Turlapati R, Swapna M, Vidyadhari M, Saranaya G, Himaja K, Deenadayal M, Kumar Sethi B, Deb P, Gupta N, Chakraborthy B, Nallari P, Singh L. Unique case reports associated with ovarian failure: necessity of two intact x chromosomes. Case Rep Genet 2012; 2012:640563. [PMID: 23074690 PMCID: PMC3447217 DOI: 10.1155/2012/640563] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2011] [Accepted: 02/07/2012] [Indexed: 11/18/2022] Open
Abstract
Premature ovarian failure is defined as the loss of functional follicles below the age of 40 years and the incidence of this abnormality is 0.1% among the 30-40 years age group. Unexplained POF is clinically recognized as amenorrhoea (>6 months) with low level of oestrogen and raised level of Luteinizing Hormone (LH) and Follicle Stimulating Hormone (FSH > 20 IU/l) occurring before the age of 40. It has been studied earlier that chromosomal defects can impair ovarian development and its function. Since there is paucity of data on chromosomal defects in Indian women, an attempt is made to carry out cytogenetic evaluation in patients with ovarian failure. Cytogenetic analysis of women with ovarian defects revealed the chromosome abnormalities to be associated with 14% of the cases analyzed. Interestingly, majority of the abnormalities involved the X-chromosome and we report two unique abnormalities, (46,XXdel(Xq21-22) and q28) and (mos,45XO/46,X+ringX) involving X chromosome in association with ovarian failure. This study revealed novel X chromosome abnormalities associated with ovarian defects and these observations would be helpful in genetic counseling and apart from, infertility clinics using the information to decide suitable strategies to help such patients.
Collapse
Affiliation(s)
- Lakshmi Rao Kandukuri
- Clinical Research Facility-Medical Biotechnology, Centre for Cellular and Molecular Biology, Annexe II, Hyderabad 500007, India
- Genome Foundation, Centre for Cellular and Molecular Biology, Hyderabad 500007, India
| | - Venkata Padmalatha
- Clinical Research Facility-Medical Biotechnology, Centre for Cellular and Molecular Biology, Annexe II, Hyderabad 500007, India
| | - Murthy Kanakavalli
- Clinical Research Facility-Medical Biotechnology, Centre for Cellular and Molecular Biology, Annexe II, Hyderabad 500007, India
| | - Raseswari Turlapati
- Clinical Research Facility-Medical Biotechnology, Centre for Cellular and Molecular Biology, Annexe II, Hyderabad 500007, India
| | - Mangalipally Swapna
- Clinical Research Facility-Medical Biotechnology, Centre for Cellular and Molecular Biology, Annexe II, Hyderabad 500007, India
- Genome Foundation, Centre for Cellular and Molecular Biology, Hyderabad 500007, India
| | - Metuku Vidyadhari
- Clinical Research Facility-Medical Biotechnology, Centre for Cellular and Molecular Biology, Annexe II, Hyderabad 500007, India
- Genome Foundation, Centre for Cellular and Molecular Biology, Hyderabad 500007, India
| | - Govindaraghavan Saranaya
- Clinical Research Facility-Medical Biotechnology, Centre for Cellular and Molecular Biology, Annexe II, Hyderabad 500007, India
- Genome Foundation, Centre for Cellular and Molecular Biology, Hyderabad 500007, India
| | - Kattera Himaja
- Clinical Research Facility-Medical Biotechnology, Centre for Cellular and Molecular Biology, Annexe II, Hyderabad 500007, India
- Genome Foundation, Centre for Cellular and Molecular Biology, Hyderabad 500007, India
| | - Mamata Deenadayal
- Infertility Institute and Research Centre, Secunderabad 500063, India
| | | | - Prasun Deb
- Krishna Institute of Medical Sciences, Hyderabad 500016, India
| | - Nalini Gupta
- Institute of Reproductive Medicine, Kolkata 700064, India
| | | | - Pratibha Nallari
- Department of Genetics, Osmania University, Hyderabad 500007, India
| | - Lalji Singh
- Clinical Research Facility-Medical Biotechnology, Centre for Cellular and Molecular Biology, Annexe II, Hyderabad 500007, India
- Genome Foundation, Centre for Cellular and Molecular Biology, Hyderabad 500007, India
| |
Collapse
|
3
|
Crain DA, Janssen SJ, Edwards TM, Heindel J, Ho SM, Hunt P, Iguchi T, Juul A, McLachlan JA, Schwartz J, Skakkebaek N, Soto AM, Swan S, Walker C, Woodruff TK, Woodruff TJ, Giudice LC, Guillette LJ. Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing. Fertil Steril 2008; 90:911-40. [PMID: 18929049 DOI: 10.1016/j.fertnstert.2008.08.067] [Citation(s) in RCA: 300] [Impact Index Per Article: 18.8] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2008] [Accepted: 08/13/2008] [Indexed: 12/21/2022]
Abstract
OBJECTIVE To evaluate the possible role of endocrine-disrupting compounds (EDCs) on female reproductive disorders emphasizing developmental plasticity and the complexity of endocrine-dependent ontogeny of reproductive organs. Declining conception rates and the high incidence of female reproductive disruptions warrant evaluation of the impact of EDCs on female reproductive health. DESIGN Publications related to the contribution of EDCs to disorders of the ovary (aneuploidy, polycystic ovary syndrome, and altered cyclicity), uterus (endometriosis, uterine fibroids, fetal growth restriction, and pregnancy loss), breast (breast cancer, reduced duration of lactation), and pubertal timing were identified, reviewed, and summarized at a workshop. CONCLUSION(S) The data reviewed illustrate that EDCs contribute to numerous human female reproductive disorders and emphasize the sensitivity of early life-stage exposures. Many research gaps are identified that limit full understanding of the contribution of EDCs to female reproductive problems. Moreover, there is an urgent need to reduce the incidence of these reproductive disorders, which can be addressed by correlative studies on early life exposure and adult reproductive dysfunction together with tools to assess the specific exposures and methods to block their effects. This review of the EDC literature as it relates to female health provides an important platform on which women's health can be improved.
Collapse
|